Orient Pharma Co., Ltd. (4166.TWO)

TWD 37.1

(-2.5%)

Operating Income Summary of Orient Pharma Co., Ltd.

  • Orient Pharma Co., Ltd.'s latest annual operating income in 2023 was 27.75 Million TWD , up 219.35% from previous year.
  • Orient Pharma Co., Ltd.'s latest quarterly operating income in 2024 Q2 was 59.74 Million TWD , down 0.0% from previous quarter.
  • Orient Pharma Co., Ltd. reported an annual operating income of -33.73 Million TWD in 2022, up 67.69% from previous year.
  • Orient Pharma Co., Ltd. reported an annual operating income of -104.39 Million TWD in 2021, up 34.87% from previous year.
  • Orient Pharma Co., Ltd. reported a quarterly operating income of 59.74 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • Orient Pharma Co., Ltd. reported a quarterly operating income of 12.26 Million TWD for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Orient Pharma Co., Ltd. (2023 - 2019)

Historical Annual Operating Income of Orient Pharma Co., Ltd. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 27.75 Million TWD 219.35%
2022 -33.73 Million TWD 67.69%
2021 -104.39 Million TWD 34.87%
2020 -160.26 Million TWD 21.96%
2019 -205.36 Million TWD 0.0%

Peer Operating Income Comparison of Orient Pharma Co., Ltd.

Name Operating Income Operating Income Difference
Allied Biotech Corporation 88.71 Million TWD 68.716%
GeneFerm Biotechnology Co., Ltd. 153.56 Million TWD 81.928%
Easywell Biomedicals, Inc. -162.73 Million TWD 117.054%
TTY Biopharm Company Limited 1.37 Billion TWD 97.978%
Synmosa Biopharma Corporation 614.74 Million TWD 95.485%
Orient EuroPharma Co., Ltd. 84.55 Million TWD 67.177%
Center Laboratories, Inc. -79.26 Million TWD 135.013%
Tien Liang BioTech Co., Ltd. 20.43 Million TWD -35.804%
InnoPharmax Inc. -64.83 Million TWD 142.803%
Johnson Chemical Pharmaceutical Works Co., Ltd. 105.57 Million TWD 73.712%
Excelsior Biopharma Inc. -81.12 Million TWD 134.209%
DV Biomed Co., Ltd. 173.54 Million TWD 84.009%
Foresee Pharmaceuticals Co., Ltd. -1 Billion TWD 102.754%
Handa Pharmaceuticals, Inc. 695.79 Million TWD 96.011%
UniPharma Co., Ltd. -27.3 Million TWD 201.641%
Anxo Pharmaceutical Co., Ltd. 53.15 Million TWD 47.787%
Alar Pharmaceuticals Inc. 385.52 Million TWD 92.801%
Winston Medical Supply Co., Ltd. 196.1 Million TWD 85.848%
Mercury Biopharmaceutical Corporation -45.69 Million TWD 160.742%
Bioray Biotech Co., Ltd -19.33 Million TWD 243.567%
TSH Biopharm Corporation Limited 63.63 Million TWD 56.384%